XML 77 R65.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Concentrations of Risk (Details) - manufacturer | 3 Months Ended | 9 Months Ended
--- | --- | ---
Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2024 | Dec. 31, 2023
Concentration Risk [Line Items] |  |  |  |
Number of third-party manufacturers | 102 | 129 | 102 | 129
Sales | Customer Concentration Risk | Walmart |  |  |  |
Concentration Risk [Line Items] |  |  |  |
Concentration risk, percentage | 20.00% | 19.00% | 20.00% | 20.00%
Sales | Customer Concentration Risk | Amazon |  |  |  |
Concentration Risk [Line Items] |  |  |  |
Concentration risk, percentage | 12.00% | 11.00% | 12.00% | 10.00%
Sales | Supplier Concentration Risk |  |  |  |
Concentration Risk [Line Items] |  |  |  |
Number of third-party manufacturers with long-term contracts |  |  | 27 | 27
Top 5 brands | Sales | Product Concentration Risk |  |  |  |
Concentration Risk [Line Items] |  |  |  |
Concentration risk, percentage | 38.00% | 37.00% | 37.00% | 38.00%
Manufacturers | Sales | Supplier Concentration Risk |  |  |  |
Concentration Risk [Line Items] |  |  |  |
Concentration risk, percentage |  |  | 73.00% | 72.00%
Contract Pharmacal Corporation | Sales | Supplier Concentration Risk |  |  |  |
Concentration Risk [Line Items] |  |  |  |
Concentration risk, percentage |  |  | 21.00% | 20.00%

X
- Definition Number of Third-party Manufacturers + References No definition available. + Details
Name: | pbh_NumberOfThirdPartyManufacturers
Namespace Prefix: | pbh_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of Third-party Manufacturers with Long-term Contracts + References No definition available. + Details
Name: | pbh_NumberOfThirdPartyManufacturersWithLongTermContracts
Namespace Prefix: | pbh_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 954 -SubTopic 310 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2 + Details
Name: | us-gaap_ConcentrationRiskLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=pbh_WalmartMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=pbh_AmazonMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_TopFiveBrandsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_ManufacturesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_ContractPharmacalCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |